concept

NLRP3 INFLAMMASOME ACTIVATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NLRP3 INFLAMMASOME ACTIVATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

51Connections

9Hypotheses

2Analyses

13Outgoing

38Incoming

20Experiments

2Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	NLRP3 INFLAMMASOME ACTIVATION

Pathway Diagram

graph TD
    NLRP3_INFLAMMASOME_ACTIVATION["NLRP3 INFLAMMASOME ACTIVATION"]
    NLRP3_INFLAMMASOME_ACTIVATION -->|"mediates"| Pyroptosis["Pyroptosis"]
    NLRP3_INFLAMMASOME_ACTIVATION -->|"activates"| IL_1_["IL-1Beta"]
    NLRP3_INFLAMMASOME_ACTIVATION -->|"activates"| IL_18["IL-18"]
    NLRP3_INFLAMMASOME_ACTIVATION -->|"activates"| IL1B["IL1B"]
    NLRP3_INFLAMMASOME_ACTIVATION -->|"activates"| IL18["IL18"]
    USP22["USP22"] -->|"inhibits"| NLRP3_INFLAMMASOME_ACTIVATION
    TREM2_Deficiency["TREM2 Deficiency"] -->|"causes"| NLRP3_INFLAMMASOME_ACTIVATION
    USP5["USP5"] -->|"inhibits"| NLRP3_INFLAMMASOME_ACTIVATION
    TREM2["TREM2"] -->|"regulates"| NLRP3_INFLAMMASOME_ACTIVATION
    NEK7["NEK7"] -->|"promotes"| NLRP3_INFLAMMASOME_ACTIVATION
    Autophagic_Degradation["Autophagic Degradation"] -->|"inhibits"| NLRP3_INFLAMMASOME_ACTIVATION
    Lps["Lps"] -->|"activates"| NLRP3_INFLAMMASOME_ACTIVATION
    Atp["Atp"] -->|"activates"| NLRP3_INFLAMMASOME_ACTIVATION

Outgoing (13)

Target	Relation	Type	Str
Neuroinflammation	mediates	process	0.92
IL-1Β	associated_with	protein	0.90
IL-18	associated_with	protein	0.90
Neuroinflammation	contributes_to	process	0.90
inflammation	drives	process	0.90
Neurodegenerative Disorders	contributes_to	disease	0.90
IL-1Β	activates	protein	0.90
IL-18	activates	protein	0.90
IL1B	activates	protein	0.90
IL18	activates	protein	0.90
Pyroptosis	mediates	process	0.90
Neurodegeneration	contributes_to	disease	0.90
Renal Tubular Epithelial Cell Apoptosis	mediates	phenotype	0.85

Incoming (38)

Source	Relation	Type	Str
TREM2 Deficiency	causes	mechanism	0.95
USP22	inhibits	protein	0.95
TREM2 Deficiency	associated_with	mechanism	0.95
TREM2	regulates	gene	0.95
NEK7	promotes	protein	0.94
TLR2 inhibition	suppresses	process	0.92
Alzheimer'S	associated_with	disease	0.90
Autophagic Degradation	inhibits	process	0.90
Atp	activates	compound	0.90
Lps	activates	compound	0.90
STING Activation	activates	mechanism	0.90
Hesperetin	inhibits	compound	0.90
cGAS-STING Pathway	activates	pathway	0.90
Autophagy	inhibits	process	0.88
ATG5	mediates	protein	0.85
Mitophagy	inhibits	process	0.85
Microglia	mediates	cell_type	0.85
Mitochondrial ROS	activates	biomarker	0.85
Nigericin	activates	compound	0.85
NOD-Like Receptor Signaling Pathway	mediates	pathway	0.85
Lps	associated_with	compound	0.85
α-Synuclein	activates	protein	0.85
cGAS-STING pathway	regulates	pathway	0.85
Complement Pathway	interacts_with	pathway	0.82
Ubiquitination	regulates	process	0.80
TREM2	inhibits	gene	0.80
PYCARD	involved_in	gene	0.80
AMPK	associated_with	protein	0.80
AMPK	regulates	gene	0.75
CSF1R modulators	inhibits	drug	0.75
Galectin-3 deletion	inhibits	gene	0.70
Lysosomal membrane permeabilization	causes	mechanism	0.70
Acid sphingomyelinase	regulates	protein	0.60
SREBF2	regulates	gene	0.60
PYCARD	participates_in	gene	0.58
IL1B	participates_in	gene	0.58
CASP1	participates_in	gene	0.58
NLRP3	participates_in	gene	0.58

Targeting Hypotheses (9)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S	0.822	neurodegeneration	What are the mechanisms by which gut mic
Astrocyte-Microglia Communication Rebalancing via Cytokine M	0.655	neurodegeneration	Which cell types show the most significa
Microbial Inflammasome Priming Prevention	0.653	neurodegeneration	What are the mechanisms by which gut mic
Galectin-3 deletion attenuates NLRP3 inflammasome activation	0.650	neuroscience	Lysosomal dysfunction and cathepsin leak
NLRP3/Mitophagy Coupling Modulation	0.646	Neuroinflammation	Immune atlas neuroinflammation analysis

Peripheral-to-Central Inflammation Circuit Breaker	0.626	-	Blood-brain barrier tight junction disru
Selective cathepsin B inhibition prevents cathepsin leakage-	0.620	neuroscience	Lysosomal dysfunction and cathepsin leak
Cardiovascular-Neuroinflammation Crosstalk Interruption	0.587	Alzheimer's disease	Neuroinflammation and microglial priming
NLRP3 Inflammasome Blockade as Upstream Intervention to Prev	0.566	neurodegeneration	Why have numerous phase 3 clinical trial

Mentioning Analyses (2)

Scientific analyses that reference this entity

Lysosomal dysfunction and cathepsin leakage in Alzheimer disease progression

neuroscience | 2026-04-04 | 7 hypotheses Top: 0.680

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.888

Experiments (20)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
LPS-induced mouse model of depression with synaptic loss analysis	validation	depression	0.900	0.00	LPS-treated mice	proposed	N/A
Network pharmacology analysis of QTJD active compounds and pathways	exploratory	Mycoplasma pneumoniae pneumoni	0.900	0.00	computational network analysis	proposed	N/A
Bidirectional Mendelian randomization analysis of C1Q and ischemic str	exploratory	Ischemic stroke, Atheroscleros	0.900	0.00	Human genetic association data	proposed	N/A
Bidirectional Mendelian randomization analysis of C1Q and ischemic str	exploratory	Ischemic stroke (large artery	0.900	0.00	human genetic data	proposed	N/A
Molecular characterization of RBG-NLRP3 binding interaction	exploratory	atherosclerosis	0.900	0.00	purified proteins and molecula	proposed	N/A
Leukocyte gene expression analysis in COVID-19 patients	exploratory	COVID-19	0.900	0.00	human leukocytes from COVID-19	proposed	N/A
Cerebrovascular function analysis in CD2AP mutant mice	validation	Alzheimer's disease	0.900	0.00	mice	proposed	N/A
C1q neutralizing antibody intervention in depression model	validation	depression	0.850	0.00	LPS-treated mice with C1q anti	proposed	N/A
RBG effects on macrophage polarization and foam cell formation	exploratory	atherosclerosis	0.850	0.00	primary macrophages	proposed	N/A
Transcriptomic analysis of RBG effects on inflammatory gene expression	exploratory	atherosclerosis	0.800	0.00	ApoE-/- mice and cell cultures	proposed	N/A
Cell-cell interaction analysis of perivascular-microglial crosstalk	exploratory	Alzheimer's disease	0.800	0.00	AD mouse models	proposed	N/A
Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe	clinical	Neurodegeneration	0.400	0.50	in_silico	proposed	$180,000
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiation Mechanis	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk Cohorts	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
Antiviral Therapy Trial for Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Experiment: Autoimmune Hypothesis Testing in AD	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
cGAS-STING Pathway Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$7,100,000
Microbiome-Gut Barrier Signatures in ALS — Experiment Design	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
Microbiome-Gut-Brain Axis in Alzheimer's Disease — mechanism and inter	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,500,000
NLRP3 Inflammasome Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for S [PMID:41114949]	Ding YN, Li MQ, Ding PT, Wang P, Guan PP	Nano letters	2026	1
Systemic inflammation as a central player in the initiation and development of A [PMID:40841660]	Bayraktaroglu I, Ortí-Casañ N, Van Dam D	Immunity & ageing : I & A	2025	1
Cerium-doped Prussian blue biomimetic nanozyme as an amplified pyroptosis inhibi [PMID:40050873]	Ma J, Tian Y, Du C, Zhu Y, Huang W, Ding	Journal of nanobiotechnology	2025	1
Interactions between antidiabetes medications and heart-brain axis. [PMID:39639832]	Ong LT, Sia CH	Current opinion in endocrinolo	2025	1
The Molecular Mechanisms of Cognitive Dysfunction in Long COVID: A Narrative Rev [PMID:40507911]	Popa E, Popa AE, Poroch M, Poroch V, Ung	International journal of molec	2025	1
USP22 suppresses the NLRP3 inflammasome by degrading NLRP3 via ATG5-dependent au [PMID:35900990]	["Di Q", "Zhao X", "Tang H", "Li X", "Xi	Autophagy	2023	1
USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradatio [PMID:34486483]	["Cai B", "Zhao J", "Zhang Y", "Liu Y",	Autophagy	2022	1
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861]	["Han X", "Sun S", "Sun Y", "Song Q", "Z	Autophagy	2020	1
Interweaving microglial senescence and gut microbiome dynamics in Alzheimer's di [PMID:41747877]	Waghmare A, Rahangdale S, Khare K, Taksa	Molecular and cellular neurosc	2026	0
The Immuno-Glial Connectome in Alzheimer's Disease: Integrating Central and Peri [PMID:41569436]	Gopalakrishna PK, Che Mohd Nassir CMN, A	Cellular and molecular neurobi	2026	0
Elevated expression of the NLRP3 inflammasome in post-mortem brain white matter [PMID:41687275]	Otálora-Alcaraz A, Sun MC, Hofman N, Cos	Multiple sclerosis and related	2026	0
NLRP3 Inflammasome and Polycystic Ovary Syndrome (PCOS): A Novel Profile in Adip [PMID:41596350]	Alenezi SA, Alshammari K, Khan R, Amer S	International journal of molec	2026	0
Exploring the Role of Microglial Cells in the Gut-Brain Axis Communication: A Sy [PMID:40662222]	Ortiz-Samur NS, Vijaya AK, Burokas A, Me	Journal of neurochemistry	2025	0
Sepsis and the Liver. [PMID:41439929]	["Geladari E", "Kalergi A", "Evangelopou	Diseases (Basel, Switzerland)	2025	0
Nlrc4 Inflammasome Expression After Acute Myocardial Infarction in Rats. [PMID:40332346]	Borim PA, Gatto M, Mota GAF, Meirelles A	Int J Mol Sci	2025	0
Molecular links between inflammatory bowel disease and Alzheimer's disease throu [PMID:41480321]	Durairajan SSK, Singh AK, Sulaiman SM, P	World journal of gastroenterol	2025	0
Bone marrow vacuolization to curative strategies: Evolving paradigms in VEXAS sy [PMID:40784090]	["Elbadry M", "Mabed M"]	Current research in translatio	2025	0
Δ9-Tetrahydrocannabinol and cannabidiol selectively suppress toll-like receptor [PMID:40553974]	Sermet S, Finn BM, Crawford RB, Kaminski	The Journal of pharmacology an	2025	0
Nlrc4 Inflammasome Expression After Acute Myocardial Infarction in Rats. [PMID:40332346]	Borim PA, Gatto M, Mota GAF, Meirelles A	International journal of molec	2025	0
The NLRP3-inflammasome inhibitor MCC950 improves cardiac function in a HFpEF mou [PMID:39616735]	["Li S", "Withaar C", "Rodrigues P", "Zi	Biomedicine & pharmacotherapy	2024	0

Debates (2)

Multi-agent debates referencing this entity

Lysosomal membrane permeabilization releasing cathepsins triggers NLRP3 inflamma

closed · Rounds: 4 · Score: 0.76 · 2026-04-22

What are the mechanisms underlying what are the mechanisms by which gut microbio

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning NLRP3 INFLAMMASOME ACTIVATION in their description or question text

Peripheral-to-Central Inflammation Circuit Breaker

Score: 0.626 · unknown disease · 2026-04-16

## Mechanistic Overview Peripheral-to-Central Inflammation Circuit Breaker starts from the claim that modulating IL1B wi

Selective cathepsin B inhibition prevents cathepsin leakage-mediated NLRP3 infla

Score: 0.620 · neuroscience · 2026-04-22

## Mechanistic Overview Selective cathepsin B inhibition prevents cathepsin leakage-mediated NLRP3 inflammasome activati

Cardiovascular-Neuroinflammation Crosstalk Interruption

Score: 0.587 · Alzheimer's disease · 2026-04-04

# Cardiovascular-Neuroinflammation Crosstalk Interruption: Targeting Shared Inflammatory Mediators in Neurodegeneratio

NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplificati

Score: 0.566 · neurodegeneration · 2026-04-16

## Mechanistic Overview NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplification starts from t